Findings from the FinnGen study encompassing 120,000 women indicate that inherited breast cancer risk should be assessed in an increasingly
Month: December 2020
Study identifies ‘three pillars’ of good mental health for young adults
Getting good quality sleep, exercising, and eating more raw fruits and vegetables predicts better mental health and well-being in young
Unexpected discovery leads to better understanding of migraine
Massive “plumes” of glutamate, a key neurotransmitter, surging in the brain could help explain the onset of migraine with
Chronic stress? Zebrafish to the rescue
A team of researchers led by MIPT’s Allan Kalueff has studied chronic stress in zebrafish and determined that the animal
Mindfulness meditation may decrease impact of migraine
Migraine is a neurological disease that can be severely debilitating and is the second leading cause of disability worldwide. Unfortunately,
What should a successful SARS-CoV-2 vaccine do?
A lot has been written recently about the merits of different potential vaccines for SARS-CoV-2. “Merit” is generally assumed to
Mexico approves emergency use of Pfizer coronavirus vaccine
The Mexican government’s medical safety commission approved the emergency use of the Pfizer-BioNTech coronavirus vaccine Friday, making Mexico the fourth
Italy’s staggering virus toll poses uncomfortable questions
Italy could soon reclaim a record that nobody wants—the most coronavirus deaths in Europe—after the health care system again failed
Official: Please skip holiday gatherings as virus surges
Medical officials on Friday pleaded with people to forgo Christmas parties and large gatherings as the state faces a record-setting
AstraZeneca buying drug developer Alexion for $39 billion
Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion. Cambridge, England-based AstraZeneca
